INMD earnings: next report 2026-07-23, real EPS beat/miss history, analyst consensus Hold, P/E 11.01. Updated 2026-07-23.
InMode (INMD) Research Hub
InMode (INMD) trades on NASDAQ, IL in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 14.9 USD (+0.74%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 11.01, market cap 0.88B. This hub links to the full technical, earnings and options research available for INMD.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 14.9 USD (+0.74%) |
| 52-week range | 13.21 USD – 15.64 USD |
| Trend regime | Range |
| 14-day RSI | 34.6 (Bearish) |
| Trailing P/E | 11.01 |
| Market cap | 0.88B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-23 |
Available research for INMD
Covered Call on INMD: how it works, illustrative setup around the real 14.9 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INMD: how it works, illustrative setup around the real 14.9 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INMD: how it works, illustrative setup around the real 14.9 USD price, max profit/loss, breakeven and when to use it. Educational.
INMD technical analysis: range, last 14.9 USD, RSI 34.6, 52w range 13.21 USD–15.64 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is INMD in?
InMode (INMD) is classified under Healthcare (Medical - Devices), listed on NASDAQ, IL.
Is INMD in an uptrend or downtrend?
As of 2026-09-11, INMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INMD's trailing P/E ratio?
INMD's trailing P/E is 11.01, with a market cap of 0.88B. See the earnings research page for full valuation detail.
When does INMD next report earnings?
INMD is next scheduled to report earnings on 2026-07-23, with a consensus EPS estimate of 0.3327 USD.